Keywords: s-p, licenses, ara, drug, pericor, major, schering-plough
S-P licenses ARA drug from PeriCor
Article | 30 July 2007
Drug major Schering-Plough has licensed the investigational, potentially first-in-class adenosine regulating agent (ARA), from fellow USA-based PeriCor Therapeutics, a privately ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
